It has been shown that overexpression of WT IDH1 has been implicated in glioblastomas, leading to increased tumor cell growth, metabolic reprogramming including lipid biosynthesis, and decreased survival in in vivo models (87). This evidence concerns the gene IDH1 and neoplasm.